GeneHealth - Your precision medicine

Allergic Contact Dermatitis

Disease Details

Family Health Simplified

Buy Membership

Description: Allergic contact dermatitis is a skin condition characterized by redness, itching, and inflammation caused by an allergic reaction to a substance that comes into contact with the skin.
Type: Allergic contact dermatitis is primarily an acquired hypersensitivity reaction rather than a condition inherited through genetic transmission. It is classified as a Type IV hypersensitivity reaction, which involves a delayed immune response mediated by T cells. Genetic factors may influence susceptibility, but the condition is not directly inherited.
Signs And Symptoms: The symptoms of allergic contact dermatitis are very similar to the ones caused by irritant contact dermatitis, which makes the first even harder to diagnose. The first sign of allergic contact dermatitis is the presence of the rash or skin lesion at the site of exposure. Depending on the type of allergen causing it, the rash can ooze, drain or crust and it can become raw, scaled or thickened. Also, it is possible that the skin lesion does not take the form of a rash but it may include papules, blisters, vesicles or even a simple red area. The main difference between the rash caused by allergic contact dermatitis and the one caused by irritant contact dermatitis is that the latter tends to be confined to the area where the trigger touched the skin, whereas in allergic contact dermatitis the rash is more likely to be more widespread on the skin. Another characteristic of the allergic contact dermatitis rash is that it usually appears after a day or two after exposure to the allergen, unlike irritant contact dermatitis that appears immediately after the contact with the trigger.
Other symptoms may include itching, skin redness or inflammation, localized swelling and the area may become more tender or warmer. If left untreated, the skin may darken and become leathery and cracked. Pain can also be present. Dermatitis can occur anywhere on the skin, but is most common on the hands (22% of people), scattered across the body (18%), or on the face (17%).The rash and other symptoms typically occur 24 to 48 hours after the exposure; in some cases, the rash may persist for weeks. Once an individual has developed a skin reaction to a certain substance it is most likely that they will have it for the rest of their life, and the symptoms will reappear when in contact with the allergen.
Prognosis: Allergic contact dermatitis generally has a good prognosis if the allergen causing the reaction is identified and subsequently avoided. Long-term outcomes are usually favorable with prompt and appropriate management, which often includes the use of topical corticosteroids to reduce inflammation. However, symptoms can persist or recur if exposure to the allergen continues.
Onset: Allergic contact dermatitis typically has an onset that occurs 24 to 48 hours after exposure to the allergen.
Prevalence: The exact prevalence of allergic contact dermatitis (ACD) can vary based on the population studied and the methods used for diagnosis. Generally, it is estimated that ACD affects around 15-20% of the general population at some point in their lives. Prevalence rates may be higher in certain occupational settings where exposure to allergens is more common.
Epidemiology: Allergic contact dermatitis is common, affecting up to 20% of all people. People sensitive to one allergen are at an increased risk of being sensitive to others. Family members of those with allergic contact dermatitis are at higher risk of developing it themselves. Women are at higher risk of developing allergic contact dermatitis than men.
Intractability: Allergic contact dermatitis is not generally considered intractable. It can often be managed effectively by identifying and avoiding the allergen causing the reaction, using topical corticosteroids, and employing other supportive care measures. However, individual cases may vary in severity and response to treatment.
Disease Severity: Allergic contact dermatitis typically varies in severity depending on the individual's sensitivity and the extent of exposure to the allergen. Symptoms can range from mild redness and itching to severe blisters, swelling, and skin peeling.
Healthcare Professionals: Disease Ontology ID - DOID:3042
Pathophysiology: Allergic contact dermatitis is an inflammatory skin condition triggered by contact with an allergen. The pathophysiology involves a type IV hypersensitivity reaction, which is a delayed immune response. Upon initial exposure, Langerhans cells in the skin present the allergen to T-lymphocytes, leading to sensitization. Upon subsequent exposures, the sensitized T-lymphocytes recognize the allergen and release cytokines, causing inflammation, redness, and itching. The reaction typically appears 24-72 hours after exposure to the allergen.
Carrier Status: Allergic contact dermatitis is not typically associated with carrier status because it is a condition triggered by an allergic reaction to an external substance rather than a genetic inheritance pattern.
Mechanism: Allergic contact dermatitis (ACD) arises as a result of two essential stages: an induction phase, which primes and sensitizes the immune system for an allergic response, and an elicitation phase, in which this response is triggered. During the induction phase, exposure to the allergic substance (allergen) leads to its processing and presentation by immune cells, priming the immune system for a response. In the elicitation phase, subsequent contact with the same allergen, T cells directly recognize the allergen resulting in an immune response at the contact site. The allergic reaction, being mediated directly by T-cells, is classified as a Type IV hypersensitivity reaction. This classification differs from the more prevalent Type I hypersensitivity (e.g., hay fever), where allergens bind to antibodies, that subsequently trigger mast cells.
In contact allergies, the molecules responsible (allergens) are typically small and cannot be directly recognized by the immune system. These allergens can trigger a reaction only after they undergo a process called haptenization. During haptenization, the allergens bind to larger molecules (carrier proteins) naturally present in the skin. This complex of allergen and carrier protein is what the immune system detects as foreign, leading to an allergic response.
The conjugate formed is then recognized as a foreign body by the Langerhans cells (LCs) (and in some cases other Dendritic cells (DCs)), which then internalize the protein; transport it via the lymphatic system to the regional lymph nodes; and present the antigen to T-lymphocytes. This process is controlled by cytokines and chemokines – with tumor necrosis factor alpha (TNF-α) and certain members of the interleukin family (1, 13 and 18) – and their action serves either to promote or to inhibit the mobilization and migration of these LCs. As the LCs are transported to the lymph nodes, they become differentiated and transform into DCs, which are immunostimulatory in nature.
Once within the lymph glands, the differentiated DCs present the allergenic epitope associated with the allergen to T lymphocytes. These T cells then divide and differentiate, clonally multiplying so that if the allergen is experienced again by the individual, these T cells will respond more quickly and more aggressively.
White et al. have suggested that there appears to be a threshold to the mechanisms of allergic sensitization by ACD-associated allergens (1986). This is thought to be linked to the level at which the toxin induces the up-regulation of the required mandatory cytokines and chemokines. It has also been proposed that the vehicle in which the allergen reaches the skin could take some responsibility in the sensitization of the epidermis by both assisting the percutaneous penetration and causing some form of trauma and mobilization of cytokines itself.
Treatment: The clinical expression of the dermatitis can be mitigated by avoidance of the allergen. Through compliance with avoidance measures, the immune system can become less stimulated. The key to avoidance is proper evaluation and detection of the inciting allergen. However, once the immune system registers the allergen, the recognition is usually permanent.
The first step in treating the condition is appropriate recognition of the clinical problem, followed by identification of the culprit chemical and the source of that chemical. Corticosteroid creams should be used carefully and according to the prescribed directions because when overused over longer periods of time they can cause thinning of the skin. Also, in some instances such as poison ivy dermatitis calamine lotion and cool oatmeal baths may relieve itching.Unlike the more common Type I allergies (e.g. hay fever), contact allergies are not mediated by histamine, making the use of normal allergy medication (antihistamine) medication ineffective and other drugs have to be used to treat the allergic reaction.
Usually, severe cases are treated with systemic corticosteroids which may be tapered gradually, with various dosing schedules ranging from a total of 12 – 20 days to prevent the recurrence of the rash (while the chemical allergen is still in the skin, up to 3 weeks, as well as a topical corticosteroid. Tacrolimus ointment or pimecrolimus cream can also be used additionally to the corticosteroid creams or instead of these. Oral antihistamines such as diphenhydramine or hydroxyzine may also be used in more severe cases to relieve the intense itching via sedation. Topical antihistamines are not advised as there might be a second skin reaction (treatment associated contact dermatitis) from the lotion itself.
The other symptoms caused by allergic contact dermatitis may be eased with cool compresses to stop the itching. It is vital for treatment success that the trigger be identified and avoided. The discomfort caused by the symptoms may be relieved by wearing smooth-textured cotton clothing to avoid frictional skin irritation or by avoiding soaps with perfumes and dyes. Commonly, the symptoms may resolve without treatment in 2 to 4 weeks but specific medication may hasten the healing as long as the trigger is avoided. Also, the condition might become chronic if the allergen is not detected and avoided.
Identification of the allergen can be aided by the site of the dermatitis. Allergic dermatitis of the hands is often due to contact with preservatives, fragrances, metals, rubber, or topical antibiotics. Dermatitis at the front of the face is often due to gold (from jewelry and foundation), make-up, moisturizers, wrinkle creams, and topical medication. Along the eyelids as well as the sides of the head and neck, dermatitis is often caused by shampoo and conditioner dripping down from the hair. Inflammation on one side of the face often suggests transfer of an allergen from the hands or from the face of a partner.
Compassionate Use Treatment: Compassionate use treatment for allergic contact dermatitis typically involves access to therapies that are not yet approved for general use but are considered potentially beneficial. Some off-label or experimental treatments include:

1. **Tacrolimus Ointment**: While primarily used for atopic dermatitis, this immunosuppressant can be effective in reducing inflammation and itching for allergic contact dermatitis.
2. **Pimecrolimus Cream**: Similar to tacrolimus, pimecrolimus is another topical calcineurin inhibitor used off-label to manage severe cases where corticosteroids are not suitable.
3. **Dupilumab**: An injectable biologic initially approved for atopic dermatitis, it has shown promise in treating severe cases of chronic allergic contact dermatitis.
4. **Alitretinoin**: An oral retinoid used for severe chronic hand eczema, which may also help allergic contact dermatitis due to its anti-inflammatory properties.
5. **Phototherapy**: Specific UV light treatments, like narrowband UVB or PUVA, can help manage chronic cases by reducing skin inflammation and modulating immune responses.

It's important to note that these treatments should be considered and monitored by a medical professional due to potential side effects and the necessity of individualized treatment plans.
Lifestyle Recommendations: Lifestyle recommendations for allergic contact dermatitis include:

1. **Avoid Triggers**: Identify and avoid substances causing the allergic reaction. Common irritants include certain metals, fragrances, and latex.
2. **Protective Clothing**: Wear gloves and long sleeves when handling irritants. Use barrier creams or protective clothing as needed.
3. **Skin Care**: Keep the skin moisturized and avoid harsh soaps. Use hypoallergenic skincare products.
4. **Hygiene**: Wash and clean affected areas with gentle, hypoallergenic cleansers after exposure to potential allergens.
5. **Beyond Immediate Relief**: Over-the-counter antihistamines and hydrocortisone creams can help reduce itching and inflammation.
6. **Stress Management**: Implement stress-reduction techniques like yoga or meditation, as stress can exacerbate symptoms.
7. **Health Monitoring**: Regularly check the skin for signs of infection or worsening symptoms and consult a healthcare provider as needed.

By incorporating these lifestyle adjustments, individuals can better manage and prevent episodes of allergic contact dermatitis.
Medication: For allergic contact dermatitis, treatment typically involves:

1. **Avoidance of the Allergen**: The primary step is to identify and avoid the substance causing the allergic reaction.
2. **Topical Corticosteroids**: These can help reduce inflammation and itching. Over-the-counter options include hydrocortisone, while stronger versions may be prescribed by a doctor.
3. **Antihistamines**: Oral antihistamines like diphenhydramine (Benadryl) can help alleviate itching and discomfort.
4. **Emollients and Moisturizers**: Regular use of these can help restore the skin barrier and reduce dryness.
5. **Oral Corticosteroids**: In severe cases, a doctor may prescribe oral corticosteroids for a short period.
6. **Calamine Lotion**: This can provide soothing relief for itching.

It's essential to consult a healthcare provider for an accurate diagnosis and appropriate treatment plan.
Repurposable Drugs: For allergic contact dermatitis, repurposable drugs include topical corticosteroids and oral antihistamines. Topical corticosteroids, such as hydrocortisone and betamethasone, can help reduce inflammation and itching. Oral antihistamines like cetirizine and diphenhydramine can help manage allergic reactions and associated itching.
Metabolites: Allergic contact dermatitis does not primarily involve significant systemic metabolites as it is localized to the skin. It is caused by immune response to small molecular allergens that penetrate the skin, and common allergens include substances like nickel, fragrances, and certain preservatives. These allergens trigger a T-cell mediated inflammatory reaction upon re-exposure.
Nutraceuticals: For allergic contact dermatitis, there is limited scientific evidence supporting the use of nutraceuticals specifically for this condition. Nutraceuticals, which are products derived from food sources with additional health benefits, are not commonly recognized as a primary treatment for allergic contact dermatitis. It is essential to focus on avoiding known allergens and using topical corticosteroids or other prescribed medications for managing symptoms. Always consult with a healthcare provider before starting any new supplement or treatment.
Peptides: For allergic contact dermatitis (ACD), peptides may be investigated as potential treatments or therapeutic agents. They could help modulate the immune response involved in ACD or assist in skin repair. Nanotechnology (nan) can play a role in enhancing the delivery of therapeutic agents, including peptides, directly to the affected skin areas, improving efficacy and reducing side effects.